US Patent 8741836 Polypeptides
Patent 8741836 was granted and assigned to Novo Nordisk on June, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Dec, 2023
Golden AI
Edits made to:
Article (+229 characters)
Article
Patent abstract
The invention relates to polypeptides comprising an amino acid sequence which is an analogue of pramlintide, pharmaceutical compositions comprising these polypeptides, and these polypeptides for use as medicaments.
Edits on 25 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Henning Thoegersen0
Lauge Schaeffer0
Thomas Kruse0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08741836 Polypeptides US Patent 8741836 Polypeptides
Infobox
Patent Number
087418360
Patent Number
87418360
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087418360
Date of Patent
June 3, 2014
0Patent Application Number
134918830
Date Filed
June 8, 2012
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08741836 Polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08741836
Date of patent
June 3, 2014
Patent application number
13491883
Date Filed
June 8, 2012
Patent primary examiner
Find more entities like US Patent 8741836 Polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
